KPMG's US Blockchain Leader: DLT will help streamline the drug supply chain

According to Cointelegraph, KPMG is excited about the future of the blockchain in the pharmaceutical supply chain. Arun Ghosh, head of the US blockchain, explains that DLT will help simplify such supply chains, which sometimes operate in intricate ways. . “The pharmaceutical supply chain is very complex, involving a large number of entities and increasingly dependent on the use of contracted manufacturers/packers, repackers and third party logistics (3PL) providers. In addition, joint collaboration and alliances between marketing licensees Licensing partnerships result in the need to share information and operate on immutable records. The blockchain is ideal for tracking the supply of prescription drugs because it provides a private, licensed network and an immutable database. In other words, multiple participations The parties can access the same data in their respective security environments (ie their "nodes")."